Older adults first in line for RSV vaccines, but will they roll up their sleeves?
August 03, 2023 12 min read Source/Disclosures Published by: Source: Healio Interviews Disclosures: Cohn, Iroku-Malize, Nace and Schaffner report no
Read More
DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
Infectious Disease
Leprosy cases in Florida suggest infection is endemic in Southeast US
August 03, 2023 3 min read Source/Disclosures Published by: Disclosures: Spencer reports no relevant financial disclosures. Please see the study
Read More
Researchers confirm dosing, efficacy of pediatric HIV drug combination
August 03, 2023 2 min read Source/Disclosures Disclosures: Brooks reports receiving consulting fees from ViiV Healthcare. Please see the study
Read More
Increasing COVID vaccine, booster uptake in Black patients requires empathy, conversation
August 01, 2023 1 min read Source/Disclosures Published by: Disclosures: Ezeh reports no relevant financial disclosures. Please see the study
Read More
One in six toddlers did not complete childhood vaccination series before COVID-19
August 02, 2023 3 min read ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on
Read More
NIH picks Marrazzo to replace Fauci as head of NIAID
August 02, 2023 1 min read Source/Disclosures Published by: Disclosures: Tabak reports no relevant financial disclosures. ADD TOPIC TO EMAIL
Read More
Survey shows only 68% of people with hepatitis C aware of the infection
Source/Disclosures Published by: Disclosures: The authors report no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when
Read More
Women more likely to leave academic medicine; issue ‘needs a systemic solution’
Source/Disclosures Disclosures: Chen and colleagues report no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new
Read More
NIH launches clinical trials testing treatments for long COVID symptoms
Source/Disclosures Disclosures: Healio was unable to confirm relevant financial disclosures at the time of publication. ADD TOPIC TO EMAIL ALERTS
Read More
Investigational 21-Valent Pneumococcal Conjugate Vaccine Immunogenic, Safe
Merck’s investigational 21-valent pneumococcal conjugate vaccine, V116, elicited positive immune responses in vaccine-naïve and previously vaccinated individuals, according to results
Read More